Search research articles
Contact Us
Filters
Showing results (31-40 of 3,929) with videos related to
Page
of 393
Sort By:
Pharmacoeconomics
|
November 8, 2017
Economic Evaluation of Implementing a Novel Pharmacogenomic Test (IDgenetix<sup>®</sup>) to Guide Treatment of Patients with Depression and/or Anxiety
Mehdi Najafzadeh, Jorge A Garces, Alejandra Maciel
Pharmacoeconomics
|
August 10, 2016
Publication of Cost-of-Illness Studies: Does Methodological Complexity Matter?
T Joseph Mattingly, C Daniel Mullins, Eberechukwu Onukwugha
Pharmacoeconomics
|
June 1, 2015
A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE)
Feng Xie, A Simon Pickard, Paul F M Krabbe, et al.
Pharmacoeconomics
|
February 5, 2025
EQ-5D-5L or EQ-HWB-S: Which is the Better Instrument for Capturing Spillover Effects in Parental Carers of Children with COVID-19?
Wenjing Zhou, Bo Ding, Jan Busschbach, et al.
Pharmacoeconomics
|
February 7, 2025
Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology
Astrid Kramer, Lucas F van Schaik, Daan van den Broek, et al.
Pharmacoeconomics
|
January 11, 2025
Projections of Public Spending on Pharmaceuticals: A Review of Methods
Irina Odnoletkova, Patrice X Chalon, Stephan Devriese, et al.
Pharmacoeconomics
|
January 17, 2025
Acceptance of Evidence Transfer Within German Early Benefit Assessment of New Drugs for Pediatric and Adolescents Target Populations
Georgia Pick, Dirk Müller, Charalabos-Markos Dintsios
Pharmacoeconomics
|
December 6, 2024
Value of Innovative Multiple Myeloma Treatments from Patient and Healthcare Provider Perspectives: Evidence from a Discrete Choice Experiment
Sakil Syeed, Chia Jie Tan, Amandeep Godara, et al.
Pharmacoeconomics
|
December 5, 2024
How Does Bereavement Affect the Health-Related Quality of Life of Household Members Who Do and Do Not Provide Unpaid Care? Difference-in-Differences Analyses Using the UK Household Longitudinal Survey
Becky Pennington, Mónica Hernández Alava, Mark Strong
Pharmacoeconomics
|
December 4, 2024
Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast Cancer
Trang T H Nguyen, Shweta Mital
Page
of 393
Search research articles
Search
Showing results (31-40 of 3,929) with videos related to
Sort By:
Page
of 393
Pharmacoeconomics
|
November 8, 2017
Economic Evaluation of Implementing a Novel Pharmacogenomic Test (IDgenetix<sup>®</sup>) to Guide Treatment of Patients with Depression and/or Anxiety
Mehdi Najafzadeh, Jorge A Garces, Alejandra Maciel
Pharmacoeconomics
|
August 10, 2016
Publication of Cost-of-Illness Studies: Does Methodological Complexity Matter?
T Joseph Mattingly, C Daniel Mullins, Eberechukwu Onukwugha
Pharmacoeconomics
|
June 1, 2015
A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE)
Feng Xie, A Simon Pickard, Paul F M Krabbe, et al.
Pharmacoeconomics
|
February 5, 2025
EQ-5D-5L or EQ-HWB-S: Which is the Better Instrument for Capturing Spillover Effects in Parental Carers of Children with COVID-19?
Wenjing Zhou, Bo Ding, Jan Busschbach, et al.
Pharmacoeconomics
|
February 7, 2025
Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology
Astrid Kramer, Lucas F van Schaik, Daan van den Broek, et al.
Pharmacoeconomics
|
January 11, 2025
Projections of Public Spending on Pharmaceuticals: A Review of Methods
Irina Odnoletkova, Patrice X Chalon, Stephan Devriese, et al.
Pharmacoeconomics
|
January 17, 2025
Acceptance of Evidence Transfer Within German Early Benefit Assessment of New Drugs for Pediatric and Adolescents Target Populations
Georgia Pick, Dirk Müller, Charalabos-Markos Dintsios
Pharmacoeconomics
|
December 6, 2024
Value of Innovative Multiple Myeloma Treatments from Patient and Healthcare Provider Perspectives: Evidence from a Discrete Choice Experiment
Sakil Syeed, Chia Jie Tan, Amandeep Godara, et al.
Pharmacoeconomics
|
December 5, 2024
How Does Bereavement Affect the Health-Related Quality of Life of Household Members Who Do and Do Not Provide Unpaid Care? Difference-in-Differences Analyses Using the UK Household Longitudinal Survey
Becky Pennington, Mónica Hernández Alava, Mark Strong
Pharmacoeconomics
|
December 4, 2024
Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast Cancer
Trang T H Nguyen, Shweta Mital
Page
of 393